These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9111708)

  • 21. Common Questions About the Pharmacologic Management of Depression in Adults.
    Kovich H; DeJong A
    Am Fam Physician; 2015 Jul; 92(2):94-100. PubMed ID: 26176368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.
    McDonagh M; Matthews A; Phillipi C; Romm J; Peterson K; Thakurta S; Guise JM
    Evid Rep Technol Assess (Full Rep); 2014 Jul; (216):1-308. PubMed ID: 30313002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-benefit analysis of antidepressant drug treatment in the elderly.
    Alamo C; López-Muñoz F; García-García P; García-Ramos S
    Psychogeriatrics; 2014 Dec; 14(4):261-8. PubMed ID: 25495088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical review of published economic modelling studies in depression.
    Jones MT; Cockrum PC
    Pharmacoeconomics; 2000 Jun; 17(6):555-83. PubMed ID: 10977394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The added costs of depression to medical care.
    Franco K; Tamburino M; Campbell N; Zrull J; Evans C; Bronson D
    Pharmacoeconomics; 1995 Apr; 7(4):284-91. PubMed ID: 10155318
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing the economic burden of depression.
    Lane R; McDonald G
    Int Clin Psychopharmacol; 1994; 9(4):229-43. PubMed ID: 7868845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The elderly and antidepressants.
    Jacoby R
    Lancet; 1993 Jul; 342(8863):113. PubMed ID: 8100877
    [No Abstract]   [Full Text] [Related]  

  • 33. Health Care of Elderly: A Viewpoint in Terms of Economic Evaluation.
    Anbazhagan S; Surekha A
    Int J Prev Med; 2018; 9():16. PubMed ID: 29541431
    [No Abstract]   [Full Text] [Related]  

  • 34. Depression in the elderly.
    Meldon SW
    Ann Emerg Med; 1999 Jun; 33(6):725. PubMed ID: 10339695
    [No Abstract]   [Full Text] [Related]  

  • 35. What is the cost of blindness?
    Meads C; Hyde C
    Br J Ophthalmol; 2003 Oct; 87(10):1201-4. PubMed ID: 14507746
    [No Abstract]   [Full Text] [Related]  

  • 36. Mirtazapine. A pharmacoeconomic review of its use in depression.
    Holm KJ; Jarvis B; Foster RH
    Pharmacoeconomics; 2000 May; 17(5):515-34. PubMed ID: 10977391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of depression in the elderly. Effects of drug therapy.
    Hughes D; Morris S; McGuire A
    Drugs Aging; 1997 Jan; 10(1):59-68. PubMed ID: 9111708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
    Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
    Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants in the elderly.
    Chiu HF
    Int J Clin Pract; 1997 Sep; 51(6):369-74. PubMed ID: 9489065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy for geriatric depression.
    Bressler R; Katz MD
    Drugs Aging; 1993; 3(3):195-219. PubMed ID: 8324296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.